DelveInsight’s “Acne Vulgaris Market Insights, Epidemiology, and Market Forecast-2032“ report delivers an in-depth understanding of the Acne Vulgaris, historical and forecasted epidemiology as well as the Acne Vulgaris market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Acne Vulgaris market report provides current treatment practices, emerging drugs, Acne Vulgaris market share of the individual therapies, and current and forecasted Acne Vulgaris market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Acne Vulgaris treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Acne Vulgaris market.
Some of the key facts of the Acne Vulgaris Market Report:
- As per Mambrin et al. (2018), acne in females is more prevalent than in male patients. The evaluation of acne severity has shown that “mild acne” is the most frequent form.
- As per Skroza et al. (2018), analyzed data from the acne outpatient database and showed that among adults, the female is more prevalent, with 85% female patients versus 15% male patients. In the adolescents, female patients were 53% versus 47% of male patients. The evaluation of acne severity showed that “mild acne” was the most frequent form in all subgroups (92% in adult females, 82% in adult males, 89% in teenage females, and 77% in teenage males, respectively).
- Additionally, the least frequent form was “severe acne” (1% in adult females, 3% in adult males, 1% in teenage females, and 1% in teenage males). Finally, “moderate acne” was observed homogeneously in all subgroups, though both male groups showed a little higher prevalence of such in comparison with the female groups (15% in adult males and 22% in teenage males versus 7% in adult females and 10% in teenage females)
Key benefits of the Acne Vulgaris Market Report:
- The report covers the descriptive overview of Acne Vulgaris, explaining its causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
- Comprehensive insight has been provided into the Acne Vulgaris epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Acne Vulgaris is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of the Acne Vulgaris market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Acne Vulgaris market
Acne Vulgaris Overview
Acne vulgaris is an inflammatory disorder of the pilosebaceous unit, which runs a chronic course and it is self-limiting. Acne vulgaris is triggered by propionibacterium acnes in adolescence, under the influence of normal circulating dehydroepiandrosterone (DHEA). Acne vulgaris is triggered by Cutibacterium acnes in adolescence, under the influence of normal circulating DHEA. It is a very common skin disorder that can present with inflammatory and non-inflammatory lesions chiefly on the face but can also occur on the upper arms, trunk, and back. Non-inflammatory: Characterized by comedones, which are sebaceous plugs impacted within follicles. They are termed open or closed depending on whether the follicle is dilated or closed at the skin surface. Plugs are easily extruded from open comedones but are more difficult to remove from closed comedones. Closed comedones are the precursor lesions to inflammatory acne. Inflammatory: Characterized by papules, pustules, nodules, and cysts. Papules and pustules occur when C. acnes colonizes the closed comedones, breaking down sebum into free fatty acids that irritate the follicular epithelium and eliciting an inflammatory response by neutrophils and then lymphocytes, which further disrupts the epithelium.
Acne Vulgaris Epidemiology Insights
- Acne may appear in adolescence, and it persists through the early thirties. During adolescence, acne vulgaris is more common in males as compared to females. In adulthood, acne vulgaris is more common in women than in men. It was also observed that about 20% of the affected individuals develop severe acne, which results in scarring. Some races appear to be more affected than others.
- Asians and Africans tend to develop severe acne, but mild acne is more common in the white population. In general, populations with darker skin also tend to develop hyperpigmentation. Acne can also develop in neonates but in most cases, resolves spontaneously. As per Bhate et al. (2013), moderate-to-severe acne affects around 20% of young people and severity correlates with pubertal maturity. As per Wolkenstein et al. (2018), the self-declared prevalence of acne is relatively high in European adolescents even if there are variations across countries. Heredity is the main identified risk factor for developing acne whereas age is negatively associated with the prevalence of this condition.
Acne Vulgaris Epidemiology Segmentation
- Acne Vulgaris (AV) Prevalence
- Acne Vulgaris (AV) Gender-specific Prevalence
- Acne Vulgaris (AV) Diagnosed and Treatable Cases
- Acne Vulgaris (AV) Severity-specific Diagnosed Prevalence
Acne Vulgaris Market Outlook
The Acne Vulgaris market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Acne Vulgaris market trends by analyzing the impact of current Acne Vulgaris therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Acne Vulgaris market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Acne Vulgaris market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Acne Vulgaris market in 7MM is expected to witness a major change in the study period 2019-2032.
Acne Vulgaris Key Companies
- BioPharmX,
- Bausch Health Americas, Inc
- And others.
Acne Vulgaris Therapies
- Retinoids and retinoid-like drug
- Tretinoin (Avita, Retin-A, others), adapalene (Differin) and tazarotene (Tazorac, Avage, others).
- Antibiotics
Table of Contents
- Key Insights
- Report Introduction
- Executive Summary of Acne Vulgaris
- Disease Background and Overview
- Epidemiology and patient population
- Acne Vulgaris Emerging Therapies
- Acne Vulgaris Market Outlook
- Market Access and Reimbursement of Therapies
- Appendix
- Acne Vulgaris Report Methodology
- DelveInsight Capabilities
- Disclaimer
Click here to read more about Acne Vulgaris Market
Media Contact
Company Name: DelveInsight Business Research
Contact Person: Adya Kaul
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432, Las Vegas NV
City: Las Vegas
State: United States
Country: United States
Website: https://www.delveinsight.com